Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Lexigram
AddedFeb 16, 2024
UpdatedJun 18, 2026
Lexigram

Lexigram

Seed

Lexigram: Providing scalable medical data extraction APIs tailored for data scientists and developers.

HQ
San Francisco, CA, US
Founded
2015
Overview
Compare
Fundraising
Employees
Website

Founded with a mission to simplify the structuring of complex healthcare data, Lexigram provides scalable medical entity and context extraction APIs. These APIs are specifically designed for data scientists and developers working with patient data. Lexigram's services focus on extracting clinical concepts from unstructured text and associating them with relevant medical codes such as ICD, HCPCS, and LOINC, thereby facilitating more efficient data management and analysis in the healthcare sector.

Lexigram has garnered attention for its innovative approach to handling unstructured medical data, making significant strides in the healthcare technology space. The company has attracted notable investors and industry experts who recognize the potential impact of its solutions. Lexigram's achievements include the successful deployment of its APIs in various healthcare settings, improving data accuracy and accessibility for numerous organizations. Through its cutting-edge technology, Lexigram continues to make a substantial impact on the way healthcare data is processed and utilized.

Lexigram - Similar Companies

ScienceIO logo

ScienceIO

science.io

Semantix logo

Semantix

us.semantix.ai

Gesund logo

Gesund

gesund.ai

MedlyticsAi logo

MedlyticsAi

Bloomapi logo

Bloomapi

bloomtext.com

Hippocratic AI logo

Hippocratic AI

hippocraticai.com

Metriport logo

Metriport

metriport.com

Textician logo

Textician

Lexer logo

Lexer

Knowtex logo

Knowtex

knowtex.ai

Medical Search Technologies logo

Medical Search Technologies

CodaMetrix logo

CodaMetrix

codametrix.com

Nlpcore logo

Nlpcore

Codes Health logo

Codes Health

codeshealth.com

Empericus logo

Empericus

Lexigram - Quick Facts

Who are Lexigram's competitors?

Companies similar to Lexigram include ScienceIO, Semantix, Gesund and MedlyticsAi.

When was Lexigram founded?

Lexigram was founded in 2015.

Where is Lexigram's headquarters located?

Lexigram's headquarters is located in San Francisco, CA, US.

When was Lexigram's last funding round?

Lexigram's most recent funding round was for $2M (USD) in November 2016.

How much has Lexigram raised to-date?

As of Nov 28, 2016, Lexigram has raised a total of $2M (USD).

How many employees does Lexigram have?

Lexigram has 10 employees as of Feb 4, 2024.

Lexigram - Classification

Ownership
  • Private
Technology
  • AI
Geographic Exposure
  • Global
Model
  • Platform
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Medical Data
Tags
  • API
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541500Computer Systems Design and Related Services
  • 541000Professional, Scientific, and Technical Services
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7371Computer Programming Services
Show 5 more industry codes
NAICS
  • 513200Software Publishers
  • 510000Information
  • 513000Publishing Industries
  • 513210Software Publishers
SIC
  • 7372Prepackaged Software